Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine sulfate + naltrexone ER vs morphine ER for moderate-to-severe cancer pain
CTR20240009Phase 3Completed
- Sponsor
- Chengdu Yuandong Biological Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Embeda in cancer pain, chronic pain, sponsored by Chengdu Yuandong Biological Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
Embeda
03
Conditions
cancer painchronic pain
Beyond the preview
Go deeper on CTR20240009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240009.